Search results
PayPal (NASDAQ:PYPL) Price Target Increased to $68.00 by Analysts at Sanford C. Bernstein
ETF DAILY NEWS· 15 hours agoPayPal (NASDAQ:PYPL – Free Report) had its price objective raised by Sanford C. Bernstein from $66.00 to $68.00 in a research note released ...
Sanford C. Bernstein Increases Canadian National Railway (TSE:CNR) Price Target to C$195.00
ETF DAILY NEWS· 3 days agoCanadian National Railway (TSE:CNR – Get Free Report) (NYSE:CNI) had its price objective hoisted by Sanford C. Bernstein from
Canadian Pacific Kansas City (TSE:CP) Given New C$118.00 Price Target at Sanford C. Bernstein
ETF DAILY NEWS· 4 days agoCanadian Pacific Kansas City (TSE:CP – Free Report) (NYSE:CP) had its target price raised by Sanford C. Bernstein ...
Boeing (NYSE:BA) Given New $240.00 Price Target at Sanford C. Bernstein
ETF DAILY NEWS· 2 weeks agoBoeing (NYSE:BA – Free Report) had its target price trimmed by Sanford C. Bernstein from $272.00 to $240.00 in a research ...
Sanford C. Bernstein Upgrades Natera (NASDAQ:NTRA) to Outperform
ETF DAILY NEWS· 2 weeks agoBernstein from a “market perform” rating to an “outperform” rating in a research report issued on Friday, Benzinga reports. The brokerage currently has a $120.00 price objective ...
EQT (NYSE:EQT) Lifted to Market Perform at Sanford C. Bernstein
ETF DAILY NEWS· 7 days agoSanford C. Bernstein upgraded shares of EQT (NYSE:EQT – Free Report) from an underperform rating to a market perform rating in a research ...
Kenvue (NYSE:KVUE) Coverage Initiated by Analysts at Sanford C. Bernstein
ETF DAILY NEWS· 1 week agoSanford C. Bernstein assumed coverage on shares of Kenvue (NYSE:KVUE – Free Report) in a research report report published on Thursday ...
Recent Investment Analysts’ Ratings Changes for Meta Platforms (META)
ETF DAILY NEWS· 17 hours ago4/18/2024 – Meta Platforms had its price target raised by analysts at Sanford C. Bernstein from $535.00 to $590.00 ...
Thermo Fisher Scientific (NYSE:TMO) PT Raised to $660.00 at HSBC
ETF DAILY NEWS· 19 hours agoThe firm currently has a “buy” rating on the medical research company’s stock. HSBC’s price target indicates a potential upside of 21.82% from the company’s current price.
Jefferies Financial Group Begins Coverage on Norfolk Southern (NYSE:NSC)
ETF DAILY NEWS· 2 weeks agoTheStreet raised shares of Norfolk Southern from a “c+” rating to a “b-” rating in a research report...